← All trials
NCT04757493
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 10, 2021
- Primary completion
- Oct 20, 2021
- Completion date
- Nov 20, 2021
- First posted
- Feb 17, 2021
- Last posted
- Oct 22, 2021
- Enrollment
- 160
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bangladesh Medical UniversityLead sponsor
- Bangladesh Medical UniversityReponsible party - principal investigator
- Bangladesh Medical UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.